These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1167 related items for PubMed ID: 29059475

  • 1. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J, Lee S.
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [Abstract] [Full Text] [Related]

  • 7. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
    Shih CJ, Chu H, Ou SM, Chen YT.
    Int J Cardiol; 2015 Nov 15; 199():283-9. PubMed ID: 26218587
    [Abstract] [Full Text] [Related]

  • 8. No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers.
    Gilbert CJ, Gomes T, Mamdani MM, Hellings C, Yao Z, Garg AX, Wald R, Harel Z, Juurlink DN.
    Can J Cardiol; 2013 May 15; 29(5):586-91. PubMed ID: 23541666
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S, Choo EH, Choi IJ, Ihm SH, Kim HY, Ahn Y, Chang K, Jeong MH, Seung KB.
    J Korean Med Sci; 2019 Nov 25; 34(45):e289. PubMed ID: 31760711
    [Abstract] [Full Text] [Related]

  • 10. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.
    Zullo AR, Riester MR, Erqou S, Wu WC, Rudolph JL, Steinman MA.
    Drugs Aging; 2020 Oct 25; 37(10):755-766. PubMed ID: 32808250
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
    Song PS, Seol SH, Seo GW, Kim DK, Kim KH, Yang JH, Hahn JY, Gwon HC, Ahn Y, Jeong MH, Song YB, Kim DI, Other Korean Working Group in Myocardial Infarction Registry Investigators.
    Am J Cardiovasc Drugs; 2015 Dec 25; 15(6):439-49. PubMed ID: 26153396
    [Abstract] [Full Text] [Related]

  • 12. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
    Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N, Interdisciplinary Chronic Disease Collaboration.
    JAMA Intern Med; 2018 Dec 01; 178(12):1681-1690. PubMed ID: 30422153
    [Abstract] [Full Text] [Related]

  • 13. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC.
    J Nephrol; 2017 Apr 01; 30(2):281-288. PubMed ID: 27485007
    [Abstract] [Full Text] [Related]

  • 14. Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).
    Kim KH, Choi BG, Rha SW, Choi CU, Jeong MH, Other KAMIR-NIH investigators.
    BMC Cardiovasc Disord; 2021 May 21; 21(1):251. PubMed ID: 34020593
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.
    Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Lee WK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Korean J Intern Med; 2016 Mar 21; 31(2):267-76. PubMed ID: 26701233
    [Abstract] [Full Text] [Related]

  • 16. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.
    JAMA Intern Med; 2014 Mar 21; 174(3):347-54. PubMed ID: 24343093
    [Abstract] [Full Text] [Related]

  • 17. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C, Ishikura K, Miura M, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Ando T, Honda M.
    Eur J Pediatr; 2016 May 21; 175(5):631-7. PubMed ID: 26687571
    [Abstract] [Full Text] [Related]

  • 18. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.
    Leon SJ, Whitlock R, Rigatto C, Komenda P, Bohm C, Sucha E, Bota SE, Tuna M, Collister D, Sood M, Tangri N.
    Am J Kidney Dis; 2022 Aug 21; 80(2):164-173.e1. PubMed ID: 35085685
    [Abstract] [Full Text] [Related]

  • 19. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

  • 20. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
    Shih CJ, Chen HT, Kuo SC, Li SY, Lai PH, Chen SC, Ou SM, Chen YT.
    CMAJ; 2016 May 17; 188(8):E148-E157. PubMed ID: 27001739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.